Collaborating for Cures

Start Date 07/03/2013

Leveraging Global Public-Private Partnerships (PPPs) to Accelerate Biopharmaceuticals Development

IMI and the Critical Path Institute(C-Path) held a joint event on the challenges and opportunities of public-private partnerships (PPPs) on 7 March 2013, at the Sheraton Hotel, Brussels Airport. More than 120 participants attended the conference and many more followed the live webcast.
This first ever public conference co-sponsored by IMI and C-Path featured cross-sector participants discussing challenges and opportunities in the rapidly-evolving PPP space. The lively discussion focused on identifying mechanisms for enhancing the productivity of PPPs, coordinating individual PPP efforts to avoid duplication, and adopting best practices on data sharing, intellectual property, patient involvement in research, and other cross-cutting issues in order to streamline biopharmaceuticals development world-wide.

  • Download the final agenda
  • Watch the entire conference on IMI's YouTube line here
  • Read the highlights of the event on Twitter at #CollaboratingForCures
  • A report on the event is being written and will be published here shortly.


Innovative solutions to shared challenges

IMI and C-Path collaboration on Alzheimer’s disease

IMI and C-Path collaboration on tuberculosis